Oculis Holding AG OCS
NASDAQ OCS
$12.17 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Oculis Holding AG (OCS) Depreciation and Depletion (2023 - 2026)

Oculis Holding AG (OCS) posted quarterly Depreciation and Depletion of $196658.7 for Q1 2026, up 43.75% year-over-year from $136806.8 in Q1 2025, and down 0.52% quarter-over-quarter from $197684.8 in Q4 2025.

Analysis

Oculis Holding AG (OCS) Depreciation and Depletion (2023 - 2026) Analysis & Trends

Oculis Holding AG's Depreciation and Depletion history runs 5 years deep, the most recent figure standing at $196658.7 for Q1 2026.

  • In Q1 2026, Depreciation and Depletion rose 43.75% year-over-year to $196658.7; the TTM figure through Mar 2026 stood at $720851.8 (up 39.89% YoY), while the FY2025 annual figure was $658546.2, up 42.7% from the prior year.
  • Depreciation and Depletion for Q1 2026 stood at $196658.7, down from $197684.8 in the prior quarter.
  • The five-year high for Depreciation and Depletion was $207604.4 in Q4 2022, with the low at $33134.6 in Q3 2022.
  • The 5-year median for Depreciation and Depletion is $136491.6 (2025), against an average of $125414.5.
  • Peak annual rise in Depreciation and Depletion reached 149.43% in 2023, while the deepest fall reached 59.82% in 2023.
  • Oculis Holding AG's Depreciation and Depletion stood at $207604.4 in 2022, then sank by 59.82% to $83424.2 in 2023, then surged by 66.94% to $139265.7 in 2024, then surged by 41.95% to $197684.8 in 2025, then fell by 0.52% to $196658.7 in 2026.
  • Business Quant data shows OCS's Depreciation and Depletion at $196658.7 in Q1 2026, $197684.8 in Q4 2025, and $190016.6 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Oculis Holding AG 634.75 Mn 345.87 Mn - 225,212.56
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 225,212.56
Mar 31, 2026 196,658.72
Dec 31, 2025 197,684.83
Sep 30, 2025 190,016.65
Jun 30, 2025 136,491.60
Mar 31, 2025 136,806.82
Dec 31, 2024 139,265.67
Sep 30, 2024 140,813.28
Jun 30, 2024 98,415.62
Mar 31, 2024 83,634.81
Dec 31, 2023 83,424.23
Sep 30, 2023 82,647.14